Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Partial Lipodystrophy peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Partial Lipodystrophy. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
1 profiles.
2025–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 15 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Partial Lipodystrophy unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT02325674
PeptideScanner retained ClinicalTrials.gov record NCT02325674 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-07-16, and PeptideScanner's reviewed identity mapping was metreleptin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- July 16, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05164341
PeptideScanner retained ClinicalTrials.gov record NCT05164341 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was metreleptin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- November 9, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT06484868
PeptideScanner retained ClinicalTrials.gov record NCT06484868 at 2026-11-16T17:35:38.955Z. Its registry update date was 2025-07-03, and PeptideScanner's reviewed identity mapping was metreleptin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- July 3, 2025
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Metreleptin · 2026-11-09
ClinicalTrials.gov record NCT05164341
Completed at the retained observation.
Open attributed record →Metreleptin · 2026-07-16
ClinicalTrials.gov record NCT02325674
Recruiting at the retained observation.
Open attributed record →Metreleptin · 2025-07-03
ClinicalTrials.gov record NCT06484868
Recruiting at the retained observation.
Open attributed record →